A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.
Lahore to Jeddah flight avoids crisis with swift emergency landing
- 9 hours ago

Bird Buddy’s solar-powered smart feeder is $100 off
- 2 hours ago

President Zardari admitted to hospital following health complications
- 12 hours ago

Facebook’s new Friends-only feed ditches all the algorithmic junk
- 2 hours ago

Four dead after speeding car plunges into Naseer Canal in Sindh
- 10 hours ago
Dozens hospitalized after massive blaze on Petronas gas pipeline in Malaysia
- 10 hours ago

Microsoft tests Quick Machine Recovery to restore PCs that can’t boot
- 2 hours ago

The Trump administration could green-light deep-sea mining for the first time
- 2 hours ago
Two dead, 12 injured in vehicle accident in Lower Dir
- 11 hours ago
Russia's Supreme Court to rule on Taliban's status as terrorist group
- 9 hours ago

Steelers' Heyward clarifies stance on Rodgers
- 43 minutes ago

Who's leading the Golden Boot races in Europe's top leagues?
- 43 minutes ago